Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-50 av 313 << Forrige 1 2 3 4 5 6 7    Neste >>

2017
1 Dale, Ola; Berntsen, Erik Magnus; Brekke, Mette; Høye, Anne; Iversen, Ole-Erik; Næss, Ane Brandtzæg; Wisborg, Torben.
Har redaksjonskomiteen fortsatt betydning?. Tidsskrift for Den norske legeforening 2017 ;Volum 137.(17)
NTNU STO UiB UiO UiT Untitled
 
2 McDonald, Rebecca; Danielsson Glende, Øyvind; Dale, Ola; Strang, John.
International patent applications for non-injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the Patent Scope database. Drug and Alcohol Review 2017
NTNU Untitled
 
3 Skulberg, Arne Kristian; Tylleskär, Ida; Skarra, Sissel; Nilsen, Turid; Salvesen, Øyvind; Dale, Ola.
Opptak og effekt av ny nesespray mot overdose. Regional forskningskonferanse 2017, Helse Midt-Norge; 2017-06-06 - 2017-06-07
NTNU Untitled
 
4 Tylleskär, Ida; Dale, Ola.
Har utviklet nesespray som redder liv. Adresseavisen [Avis] 2017-03-09
NTNU Untitled
 
5 Tylleskär, Ida; Skulberg, Arne Kristian; Nilsen, Turid; Skarra, Sissel; Jansook, Phatsawee; Dale, Ola.
Pharmacokinetics of a new, nasal formulation of naloxone. European Journal of Clinical Pharmacology 2017 ;Volum 73.(5) s. 555-562
NTNU OUS STO Untitled
 
6 Tylleskär, Ida; Skulberg, Arne Kristian; Nilsen, Turid; Skarra, Sissel; Jansook, Phatsawee; Dale, Ola.
Pharmacokinetics of nasal naloxone - basic knowledge for future prehospital use. EMS2017, European Emergency Medical Services Congress; 2017-05-22 - 2017-05-24
NTNU Untitled
 
2016
7 Dale, Ola.
Ethical issues and stakeholders matter. Addiction 2016 ;Volum 111.(4) s. 587-589
NTNU Untitled
 
8 Dale, Ola; Klepstad, Pål; Tveita, Torkjel; Thoner, Just; Borchgrevink, Petter Chr..
Re: Fra ketobemidon til morfin eller oksykodon. Tidsskrift for Den norske legeforening 2016 ;Volum 136.(23-24) s. 1957-1957
NTNU STO UNN Untitled
 
9 Landmark, Tormod; Borchgrevink, Petter Chr.; Dale, Ola.
Annual incidence of chronic pain and its relation to change in health related quality of life: The HUNt pain study. 16th World Congress on Pain; 2016-09-26 - 2016-09-30
NTNU Untitled
 
10 Landmark, Tormod; Borchgrevink, Petter Chr.; Dale, Ola.
Chronic pain, chronic depression: A prospective study in the general population. NOSF fagkonferanse 2016; 2016-01-07 - 2016-01-08
NTNU Untitled
 
11 Skorpen, Frank; von Hofacker, Sebastian; Bjørngaard, Mads; Skogholt, Anne Heidi; Dale, Ola; Kaasa, Stein; Klepstad, Pål.
The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses. Acta Anaesthesiologica Scandinavica 2016 ;Volum 60.(8) s. 1084-1091
HAUKELAND HMR HVprivate NTNU STO Untitled
 
12 Skulberg, Arne Kristian; Tylleskär, Ida; Skarra, Sissel; Nilsen, Turid; Dale, Ola.
Biotilgjenglighet og effekt av nalokson som nesespray. Norsk Selskap for Farmakologi og Toksikologis vintermøte 2016; 2016-01-28 - 2016-01-31
NTNU Untitled
 
13 Tylleskär, Ida; Skulberg, Arne Kristian; Nilsen, Turid; Skarra, Sissel; Dale, Ola.
Biotilgjengelighet av nalokson som nesespray - grunnlaget for fremtidig prehospital bruk. Norsk Selskap for Farmakologi og Toksikologis vintermøte 2016; 2016-01-28 - 2016-01-31
NTNU Untitled
 
2015
14 Barratt, Daniel T.; Klepstad, Pål; Dale, Ola; Kaasa, Stein; Somogyi, Andrew A..
Innate immune signalling genetics of pain, cognitive dysfunction and sickness symptoms in cancer pain patients treated with transdermal fentanyl. PLoS ONE 2015 ;Volum 10:0137179.(9)
NTNU STO Untitled
 
15 Dale, Ola.
Experiences from developing a nasal spray for paramedics and drug users in the community. Conference on Overdose Awareness; 2015-08-31 - 2015-09-01
NTNU Untitled
 
16 Dale, Ola.
Fra Rek- leder til grenseutfordrende bruker og Virkningsprofil av nasalt nalokson. Storfellesmøte for Forskningsetiske komiteer; 2015-10-12 - 2015-10-13
NTNU Untitled
 
17 Dale, Ola.
Nasal naloksonspray mot heroinoverdose: Tornefull vei fra ide til  produkt. Fredagsforelesning; 2015-10-02
NTNU Untitled
 
18 Dale, Ola; Borchgrevink, Petter Chr.; Fredheim, Olav Magnus; Mahic, Milada; Romundstad, Pål Richard; Skurtveit, Svetlana.
Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids. BMC Public Health 2015 ;Volum 15. s. -
AHUS FHI NTNU STO UiO Untitled
 
19 Hansen, Anneli Borge; Skurtveit, Svetlana; Borchgrevink, Petter Chr.; Dale, Ola; Romundstad, Pål Richard; Mahic, Milada; Fredheim, Olav Magnus.
Consumption of and satisfaction with health care among opioid users with chronic non-malignant pain. Acta Anaesthesiologica Scandinavica 2015 ;Volum 59.(10) s. 1355-1366
AHUS FHI NTNU STO UiO Untitled
 
20 Kurita, GP; Lundström, S; Sjøgren, P; Ekholm, O; Christrup, L; Davies, A; Kaasa, Stein; Klepstad, Pål; Dale, Ola.
Renal function and symptoms/adverse effects in opioid-treated patients with cancer. Acta Anaesthesiologica Scandinavica 2015 ;Volum 59.(8) s. 1049-1059
NTNU STO Untitled
 
21 Skulberg, Arne Kristian; Dale, Ola.
Nasal naloxone: Experience and perspectives from Norway. National Addiction Centre lecture; 2015-11-23
NTNU Untitled
 
22 Skulberg, Arne Kristian; Tylleskär, Ida; Skarra, Sissel; Dale, Ola.
Biotilgjenglighet og effekt av nalokson som nesespray sammenliknet med intramuskulær injeksjon. NAForum 2015 ;Volum 28.(3) s. 49-
NTNU Untitled
 
23 Strømmen, Magnus; Kulseng, Bård Eirik; Dale, Ola.
Increased bioavailability of alcohol following sleeve gastrectomy. Preliminary results 3 months afters surgery.. ECO2015 (European Congress on Obesity); 2015-05-06
NTNU STO Untitled
 
24 Tylleskär, Ida; Skulberg, Arne Kristian; Nilsen, Turid; Skarra, Sissel; Jansook, Phatsawee; Dale, Ola.
Biotilgjenlighet av nalokson som nesespray - grunnlaget for fremtidig prehospital bruk. Skandinavisk Akuttmedisin 2015; 2015-03-17 - 2015-03-18
NTNU Untitled
 
2014
25 Barratt, DT; Bandak, B; Klepstad, Pål; Dale, Ola; Kaasa, Stein; Christrup, Lona L; Tuke, J; Somogyi, AA.
Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenetics & Genomics 2014 ;Volum 24.(4) s. 185-194
NTNU Untitled
 
26 Bjelland, Thor Wilhelm; Klepstad, Pål; Haugen, Bjørn Olav; Nilsen, Torbjørn; Salvesen, Øyvind; Dale, Ola.
Concentrations of remifentanil, propofol, fentanyl, and midazolam during rewarming from therapeutic hypothermia. Acta Anaesthesiologica Scandinavica 2014 ;Volum 58.(6) s. 709-715
NTNU STO Untitled
 
27 Dale, Ola.
Nasal drug administration in acute medicine. Annual meeting of the Finnish Society of Anaesthesiologists; 2014-11-27
NTNU Untitled
 
28 Fredheim, Olav Magnus; Mahic, Milada; Skurtveit, Svetlana; Dale, Ola; Romundstad, Pål Richard; Borchgrevink, Petter Chr..
Chronic pain and use of opioids: A population-based pharmacoepidemiological study from the Norwegian Prescription Database and the Nord-Trøndelag Health Study. Pain 2014 ;Volum 155.(7) s. 1213-1221
AHUS FHI NTNU STO UiO Untitled
 
29 Thronæs, Morten; Kaasa, Stein; Dale, Ola.
A pilot study of nasal fentanyl for patient controlled treatment of cancer pain. Journal of Opioid Management 2014 ;Volum 10.(1) s. 21-28
NTNU STO Untitled
 
30 Tylleskär, Ida Karin; Skulberg, Arne Kristian; Nilsen, Turid; Jansook, Phatsawee; Dale, Ola.
Preliminær biotilgjengelighet av en ny nasal formulering av nalokson. Norsk selskap for farmakologi og toksikologis vintermøte 2014; 2014-01-23 - 2014-01-26
NTNU Untitled
 
31 Tylleskär, Ida Karin; Skulberg, Arne Kristian; Nilsen, Turid; Skarra, Sissel; Jansook, Phatsawe; Dale, Ola.
Biotilgjenglighet av nalokson som nesespray- grunnlaget for fremtidig prehospital bruk. NAForum 2014 ;Volum 27.(3) s. 49-
NTNU Untitled
 
32 Tylleskär, Ida; Skulberg, Arne Kristian; Nilsen, Turid; Skarra, Sissel; Jansook, Phatsawee; Dale, Ola.
Bioavailability of nasal naloxone - the knowledge base for further clinical research in this field. Frampeik 2014; 2014-10-24 - 2014-10-26
NTNU Untitled
 
2013
33 Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav.
Clopidogrel does not work following cardiopulmonary resuscitation. European Journal of Clinical Pharmacology 2013
NTNU STO UIS Untitled
 
34 Bjelland, Thor Wilhelm; Klepstad, Pål; Haugen, Bjørn Olav; Nilsen, Turid; Dale, Ola.
Effects of hypothermia on the disposition of morphine, midazolam, fentanyl, and propofol in intensive care unit patients. Drug Metabolism And Disposition 2013 ;Volum 41.(1) s. 214-223
NTNU STO Untitled
 
35 ; Shrestha, Rinu.
Quantification of doxorubicin in mouse serum and tumor tissue by liquid chromatography tandem mass spectrometry. : NTNU 2013 196 s.
NTNU Untitled
 
36 Fladvad, Torill; Klepstad, Pål; Langaas, Mette; Dale, Ola; Kaasa, Stein; Caraceni, Augusto; Skorpen, Frank.
Variability in UDP-glucuronosyltransferase genes and morphine metabolism. Observations from a cross-sectional multicenter study in advanced cancer patients with pain. Pharmacogenetics & Genomics 2013 ;Volum 23.(3) s. 117-126
NTNU STO Untitled
 
37 Husum, B; Stenqvist, O; Alahuhta, S; Sigurdsson, GH; Dale, Ola.
Current use of nitrous oxide in public hospitals in Scandinavian countries. Acta Anaesthesiologica Scandinavica 2013 ;Volum 57.(9) s. 1131-1137
NTNU Untitled
 
38 Landmark, Tormod; Romundstad, Pål Richard; Borchgrevink, Petter Chr.; Kaasa, Stein; Dale, Ola.
Longitudinal Associations between Exercise and Pain in the General Population - The HUNT Pain Study. PLoS ONE 2013 ;Volum 8.(6) s. -
NTNU STO Untitled
 
39 Landmark, Tormod; Romundstad, Pål Richard; Dale, Ola; Borchgrevink, Petter; Vatten, Lars Johan; Kaasa, Stein.
Chronic pain: One year prevalence and associated characteristics (the HUNT pain study). Scandinavian Journal of Pain 2013 ;Volum 4.(4) s. 182-187
NTNU STO Untitled
 
40 Paulsen, Ørnulf; Aass, Nina Kathrine; Kaasa, Stein; Dale, Ola.
Do coricosteroids provide anlgesic effects in cancer patients? A systeamtic literature review. Journal of Pain Symptom and Management 2013 ;Volum 46.(1) s. 96-105
NTNU OUS STHF STO UiO Untitled
 
41 Paulsen, Ørnulf; Aass, Nina Kathrine; Kaasa, Stein; Dale, Ola.
Do Corticosteroids Provide Analgesic Effects in Cancer Patients? A Systematic Literature Review. Journal of Pain Symptom and Management 2013 ;Volum 46.(1) s. 96-105
NTNU OUS STHF STO UiO Untitled
 
2012
42 Andreassen, Trine Naalsund; Eftedal, Ingrid; Klepstad, Pål; Davies, Andrew; Bjordal, Kristin; Lundström, Staffan; Kaasa, Stein; Dale, Ola.
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional mutlicentre study. European Journal of Clinical Pharmacology 2012 ;Volum 68.(1) s. 55-64
NTNU OUS STO Untitled
 
43 Andreassen, Trine Naalsund; Klepstad, Pål; Davies, Andrew; Bjordal, Kristin; Lundström, Staffan; Kaasa, Stein; Dale, Ola.
Is Oxycodone Efficacy Reflected in Serum Concentrations? A Multicenter, Cross-Sectional Study in 456 Adult Cancer Patients. Journal of Pain Symptom and Management 2012 ;Volum 43.(4) s. 694-705
NTNU OUS STO Untitled
 
44 Bjelland, Thor Wilhelm; Dale, Ola; Kaisen, Kjell; Haugen, Bjørn Olav; Lydersen, Stian; Strand, Kristian; Klepstad, Pål.
Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial. Intensive Care Medicine 2012 ;Volum 38.(6) s. 959-967
NTNU STO SUS Untitled
 
45 Bjelland, Thor Wilhelm; Dale, Ola; Kaisen, Kjell; Haugen, Bjørn Olav; Lydersen, Stian; Strand, Kristian; Klepstad, Pål.
Sedasjon og analgesi under terapeutisk hypotermi: propofol og remifentanil versus fentanyl og midazolam. En randomisert, kontrollert studie. NSFTs Vintermøte nr. 40; 2012-01-26
NTNU SUS Untitled
 
46 Caraceni, Augusto; Hanks, Geoffrey; Kaasa, Stein; Bennett, Michael I; Brunelli, C; Cherny, Nathan; Dale, Ola; De Conno, Franco; Fallon, M; Hanna, M; Haugen, Dagny Faksvåg; Juhl, Gitte Irene; King, S.; Klepstad, Pål; Laugsand, Eivor Alette; Maltoni, M; Mercadante, S.; Nabal, M; Pigni, Alessandra; Radbruch, L; Reid, C; Sjogren, Per; Stone, Patrick; Tassinari, D; Zeppetella, G.
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. The Lancet Oncology 2012 ;Volum 13.(2) s. E58-E68
HAUKELAND NTNU STO Untitled
 
47 Dale, Ola; Somogyi, AA; Li, YB; Sullivan, T; Shavit, Y.
Does Intraoperative Ketamine Attenuate Inflammatory Reactivity Following Surgery? A Systematic Review and Meta-Analysis. Anesthesia and Analgesia 2012 ;Volum 115.(4) s. 934-943
NTNU STO Untitled
 
48 Dale, Ola; Svendsen, Kristian; Borchgrevink, Petter Chr..
The Morphine Manifesto. Tidsskrift for Den norske legeforening 2012 ;Volum 132. s. 935-936
NTNU STO Untitled
 
49 Fladvad, Torill; Klepstad, Pål; Langaas, Mette; Dale, Ola; Kaasa, Stein; Caraceni, Augusto Tommaso Giovanni; Skorpen, Frank.
Variability in UDP-gluruonyltransferase genes and morphine metabolism. Observations from a cross-sectional multicenter study in advance cancer patients with pain. World Congress of the European Association for palliative care (EAPC); 2012-06-07 - 2012-06-09
NTNU Untitled
 
50 Husby, Kristin Moksnes; Kaasa, Stein; Paulsen, Ørnulf; Rosland, Jan Henrik; Spigset, Olav; Dale, Ola.
Serum concentrations of opiods when comparing two switching strategies to methadone for cancer pain. European Journal of Clinical Pharmacology 2012 ;Volum 68.(8) s. 1147-1156
HVprivate NTNU STHF STO UiB Untitled
 
    Vis neste liste